

Cencora (NYSE:COR) reported fourth-quarter financial results on Wednesday. The transcript from the company’s fourth-quarter earnings call has been provided...
You can purchase shares of Cencora (NYSE:COR) through any online brokerage.
Other companies in Cencora’s space includes: McKesson Corp (NYSE:MCK), Cardinal Health Inc (NYSE:CAH), Henry Schein Inc (NASDAQ:HSIC), AdaptHealth Corp (NASDAQ:AHCO) and Akso Health Group (NASDAQ:AHG).
Cencora has a consensus price target of $350.75.
The stock price for Cencora (NYSE: COR) is $355 last updated November 4, 2026 at 5:15 PM EST.
There are no upcoming dividends for Cencora.
Cencora does not have any upcoming earnings scheduled.
There is no upcoming split for Cencora.
Cencora is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare...